Popular on TelAve
- Nutrition and Wellness Expert, Chaitra Dalton Bryant Joins the Board of the National Minority Health Association to Reduce Health Inequities
- Keep Black Love Alive --Spelman Women's Research and Resource Center and chromatic black™ Sponsor Well-Being Advocacy Forum
- G. ENTERTAINMENT proudly presents Indianapolis' Inaugural Juneteenth Celebration Weekend Kick-Off with the "What the Funk" Concert
- FTC Award-Winning Innovator Nukes Robocalls and Spam Texts with Nomorobo Max
- Linksys and Axiros Collaborate to Provide Whole Home Coverage and Deep Insight into WiFi Network
- What Happens to Student Loans After Someone Dies?
- Anduin Becomes Aiwyn, Announces Market Expansion
- Genesis Homes is ready to take over the Cape Coral real estate market in South Florida
- Pvilion and Atlantic Council Build Solar Powered Resiliency Pod to Serve Miami Community
- History-making Footwear Brand TRONUS Announces Exciting New Partnerships And Products As Company Expands This Summer
Similar on TelAve
- Mutual Aid Ambulance Service Partners with Excela Health for Paramedic Training Program
- Virtual Workplace Platform Developer REACH Expands Executive Team, Positioning the Company to Drive International Growth
- Health Advisory: Protecting Yourself and Others from Monkeypox
- Kano Laboratories, Makers of Kroil, Announces Refreshed Branding for Extended Line of Industrial Product Solutions
- Fathym announces the addition of Sergio Sotolongo to its board of directors
- Avion Medical Skin Centres to offer innovative treatment for non-melanoma skin cancer patients
- The Data Economics Company announces partnership with Incradia to release the ReVerse franchise on Lydion-based Game Development Platform
- iTech offers 60-days free trial on expEDIum Medical Billing® product
- Completion of funding round brings Metaphysiks one step closer to embodying the Metaverse
- CHASM unveils highly-respected CEO John Kawola as its first independent board member
CPC Scientific Announces New California Peptide API Manufacturing Facility
TelAve News/10746972
SAN JOSE, Calif. - TelAve -- CPC Scientific Inc., a leading global peptide CRDMO (Contract Research, Development, and Manufacturing Organization) has invested in a new peptide API (Active Pharmaceutical Ingredient) manufacturing site, bringing many new jobs to Rocklin, California. The 41,000 sq ft facility located at 3880 Atherton Rd, Rocklin, CA 95765 will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity and will diversify CPC Scientific's supply chain.
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on TelAve News
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on TelAve News
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on TelAve News
- Always Ontime: Chaos City - Super Hero Graphic Novel with Neal Adams Cover Launches from Panopolis Metaverse
- New Hampshire Becomes the 15th State to Require Personal Finance as a Core Academic Subject
- Virtual Workplace Platform Developer REACH Expands Executive Team, Positioning the Company to Drive International Growth
- Health Advisory: Protecting Yourself and Others from Monkeypox
- Kindle FREE June 28-29: Powerful new memoir from Santa Molina-Marshall poised to help heal abuse victims through inspiring storytelling
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on TelAve News
- GoodLoan.io announces new program to unlock up to $500,000 for Home Equity Investment
- Beck Properties Group Hires Professional Marketing Team
- Cosplay Universe" Documentary to Premiere at Anime Expo & in Theaters this Summer
- Kano Laboratories, Makers of Kroil, Announces Refreshed Branding for Extended Line of Industrial Product Solutions
- Fathym announces the addition of Sergio Sotolongo to its board of directors
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
Source: CPC Scientific Inc.
Filed Under: Technology
0 Comments
Latest on TelAve News
- New development in Ramsey called Williams Woods!
- Top New Jersey Engagement Shoot Locations and couples who totally nailed it
- BEC Technologies RidgeWave® 7000 Series Achieves AT&T Certification
- Calgary-based Orthodontics Provider Opens New Location
- Entrinsik Promotes Robin Lamb to Vice President of Client Services
- Announcing The Christina Hepburn Breast Cancer Support Campaign
- Altavoz Distribution Launches Regina Belle Records
- Robinson honored again by both Rolls-Royce and The Fabricator for excellence
- Abendroth Fortel Offers Financial Support to Develop Agricultural Products Supply Chains
- Keep Black Love Alive --Spelman Women's Research and Resource Center and chromatic black™ Sponsor Well-Being Advocacy Forum
- THine V-by-One® HS Technology Used in NVIDIA G-SYNC® Processor
- Console & Associates: The Passing of the Camp Lejeune Act Puts Justice Within Reach
- Today!Mecha Infinity And Neuto House PH Signed A Charity Partnership Contract
- Oakwood Capital Completes $8.5 Million Acquisition of Apartment Complex in Valdosta, Georgia
- Rhody Rug Stands with Ukraine Creates Limited Edition Braided Rug to Support the Efforts in Ukraine
- Lux Billet Launches Stacyc Billet Foot Pegs
- Meet Mary Pitt Who Brings Real World Security, Firearms Training, State Laws, Gun Safety, Respect & Responsibility To A Diverse Group Of Clientele
- 3,000 Ukrainian Artists you can support today: an exclusive selection of 3000 artists from Ukraine
- Farm Shop MFG, LLC Launches a Comprehensive Temperature and Moisture Management System That Monitors Grain Storage Conditions
- Sidow Sobrino returns home from filming music video in Paris, France